Sana Biotechnology (SANA) News Today $3.40 +0.07 (+2.10%) Closing price 04:00 PM EasternExtended Trading$3.40 0.00 (0.00%) As of 05:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SANA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period HC Wainwright Issues Optimistic Forecast for SANA EarningsAugust 16 at 8:21 AM | marketbeat.comQ3 EPS Forecast for Sana Biotechnology Raised by AnalystAugust 16 at 3:03 AM | americanbankingnews.comSana Biotechnology Reports Non-Cash Impairment LossesAugust 14, 2025 | theglobeandmail.comBrokerages Set Sana Biotechnology, Inc. (NASDAQ:SANA) Target Price at $8.00August 14, 2025 | americanbankingnews.comSana Biotech Bails on Factory in Old AT&T Call CenterAugust 12, 2025 | finance.yahoo.comSana Biotechnology (NASDAQ:SANA) Posts Earnings Results, Beats Estimates By $0.04 EPSAugust 12, 2025 | marketbeat.comSana Biotechnology, Inc. (NASDAQ:SANA) Given Average Rating of "Buy" by BrokeragesAugust 12, 2025 | marketbeat.comSana: Q2 Earnings SnapshotAugust 11, 2025 | sfgate.comSana suspends build-out of Bothell manufacturing facilityAugust 11, 2025 | bizjournals.comSana Biotechnology: Fundraising Triggers Major Sell-Off, I'm Still IntriguedAugust 8, 2025 | seekingalpha.comSana Biotechnology (NASDAQ:SANA) Shares Gap Down - Here's What HappenedAugust 8, 2025 | marketbeat.comSeattle biotech firm Sana Biotechnology raising $75 million through public offeringAugust 8, 2025 | bizjournals.comSana Biotechnology stock tumbles after pricing public offeringAugust 7, 2025 | investing.comSana Biotechnology 20.9M share Spot Secondary priced at $3.35August 7, 2025 | msn.comSana Biotechnology Shares Tumble on Pricing of Public OfferingAugust 7, 2025 | marketwatch.comSana Biotechnology (SANA) Projected to Post Earnings on ThursdayAugust 7, 2025 | marketbeat.comSana Biotechnology Announces Pricing of Public OfferingAugust 6, 2025 | globenewswire.comSana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded WarrantsAugust 6, 2025 | tmcnet.comSana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded WarrantsAugust 6, 2025 | globenewswire.comSeres Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business UpdatesAugust 6, 2025 | globenewswire.comNovel T1D Therapy Opens the Door to Cell Transplants Sans ImmunosuppressantsAugust 6, 2025 | msn.comSana Biotechnology (NASDAQ:SANA) Trading Up 8.8% - Time to Buy?August 5, 2025 | marketbeat.comTD Asset Management Inc Cuts Stock Position in Sana Biotechnology, Inc. (NASDAQ:SANA)August 5, 2025 | marketbeat.comSana Biotechnology's HIP-Modified Pancreatic Islet Cells Show Promising Results in Type 1 Diabetes Study Without ImmunosuppressionAugust 4, 2025 | quiverquant.comQSana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 DiabetesAugust 4, 2025 | globenewswire.comSana Biotechnology (SANA) Rated ‘Market Perform’ on Diabetes Program ProspectsAugust 1, 2025 | insidermonkey.comSana Biotechnology (SANA) Rated ‘Market Perform’ on Diabetes Program ProspectsAugust 1, 2025 | finance.yahoo.comCiti Remains Bullish on Sana Biotechnology (SANA)August 1, 2025 | msn.comSana Biotechnology (NASDAQ:SANA) Trading Down 6.7% - Should You Sell?July 30, 2025 | marketbeat.comSana Biotechnology, Inc. (NASDAQ:SANA) Shares Purchased by Skandinaviska Enskilda Banken AB publJuly 30, 2025 | marketbeat.comCiti Maintained a Buy Rating on Sana Biotechnology (SANA)July 23, 2025 | msn.comSana Biotechnology (NASDAQ:SANA) Stock Price Down 5.7% - Here's What HappenedJuly 21, 2025 | marketbeat.comSana Biotechnology, Inc. (NASDAQ:SANA) Receives Average Rating of "Buy" from AnalystsJuly 17, 2025 | marketbeat.comSana Biotechnology, Inc. (SANA) Secures an Overweight Rating from Morgan StanleyJuly 11, 2025 | finance.yahoo.comSana Biotechnology (NASDAQ:SANA) Shares Gap Up - Here's WhyJuly 9, 2025 | marketbeat.comSana Biotechnology (NASDAQ:SANA) Shares Up 14.1% - Still a Buy?July 8, 2025 | marketbeat.comSana Reports Promising Diabetes Cell Therapy Data at ADA MeetingJuly 4, 2025 | msn.comSana Biotechnology (NASDAQ:SANA) Coverage Initiated by Analysts at Morgan StanleyJuly 3, 2025 | marketbeat.comSana Biotechnology (NASDAQ:SANA) Stock Price Up 7.6% - What's Next?July 2, 2025 | marketbeat.comSana Biotechnology (SANA) Stock Surges on Positive Type 1 Diabetes Treatment ResultsJune 29, 2025 | insidermonkey.comSana Biotechnology’s SWOT analysis: promising cell therapy stock faces crowded market - Investing.comJune 26, 2025 | investing.comSana Biotechnology (SANA) Receives a Buy from Citizens JMPJune 26, 2025 | theglobeandmail.comSana Biotechnology (NASDAQ:SANA) Stock Price Down 4.5% - Time to Sell?June 25, 2025 | marketbeat.comBofA Remains Bullish on Sana Biotechnology (SANA)June 24, 2025 | insidermonkey.comSana Biotechnology (NASDAQ:SANA) Given Market Outperform Rating at JMP SecuritiesJune 24, 2025 | marketbeat.comSana Biotechnology (NASDAQ:SANA) Stock Price Up 17.2% - Should You Buy?June 23, 2025 | marketbeat.comSana Biotechnology stock soars after positive diabetes treatment resultsJune 23, 2025 | investing.comTwo Biotech Stocks Poised For Big Moves On MondayJune 23, 2025 | benzinga.comSana Biotechnology Shares Climb on Positive Diabetes Study ResultsJune 23, 2025 | marketwatch.comSana Biotechnology Reports Promising Six-Month Results from First-in-Human Study on Hypoimmune-Modified Pancreatic Islet Cell Transplant for Type 1 DiabetesJune 23, 2025 | quiverquant.comQ Get Sana Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for SANA and its competitors with MarketBeat's FREE daily newsletter. Email Address SANA Media Mentions By Week SANA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SANA News Sentiment▼0.660.66▲Average Medical News Sentiment SANA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SANA Articles This Week▼1411▲SANA Articles Average Week Get Sana Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for SANA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies XENE News Today CRNX News Today ALVO News Today IMVT News Today BHC News Today KYMR News Today KNSA News Today CPRX News Today ARWR News Today OGN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SANA) was last updated on 8/18/2025 by MarketBeat.com Staff From Our PartnersWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredThe stealth altcoin the financial world is underestimatingThis DeFi project could soar next When altcoin season fully kicks in—which the data suggests is happening R...Crypto 101 Media | SponsoredMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredBut this $20 American company could control the secretThe "Impossible" Chip That Runs on Pure Light Google's quantum computer shocked the world... but China DEMO...The Oxford Club | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sana Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sana Biotechnology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access